Recently, the 8th Southern Weekend Annual Ceremony Brand Conference was held in Beijing. The conference gathered representatives of ** institutions, industry associations, business organizations, academia, ** and other fields, based on the forefront of the brand marketing field, focusing on annual phenomena and excellent cases, and exploring brand innovation paths and future trends. At the meeting, Aier Ophthalmology won the "Sustainable Brand of the Year" award, and well-known brands such as Tmall and Bosideng also won the award.
As an annual brand event, the brand conference adheres to the tenet of "sharing, innovation and exploration", is committed to mining the brand value of enterprises, analyzing and summarizing the new trends and directions of China's brand development, and selecting the representative brands and case practices of the year for the whole industry, encouraging positive innovation and promoting social progress. The "Sustainable Brand of the Year" aims to recognize brands or enterprises that "take into account both internal and external" and achieve high-quality, green and sustainable development in the process of enterprise operation and management.
In 2023, against the backdrop of sluggish global economic growth, the domestic economy will stabilize and rebound, and service consumption and other fields will begin to fully recover, and the connotation of the word "brand" will become more and more broad. As a well-known brand of ophthalmology in China and the world, Aier Ophthalmology takes "innovation-driven, science and technology" as the guiding principle and relies on the three major drivers of "technology + innovation + talent" to develop comprehensively in the fields of medicine, teaching, research, production and investment under the background of the current dominance of non-public ophthalmic medical institutions, and continues to promote the development of human eye health.
In order to realize long-term ophthalmic medical assistance for patients with difficult eye diseases, Aier Ophthalmology has explored a "hierarchical chain", effectively connected with the national medical reform policy of "hierarchical diagnosis and treatment, two-way referral", and innovatively implemented the "cross-subsidy" public welfare model, subsidizing the profits obtained from high-end medical services to low-income eye disease patients, so that the people can truly enjoy high-quality and accessible medical resources.
In order to continue to promote the basic research and technological innovation of ophthalmology, visual science, and cutting-edge and clinical application technologies of various subspecialties, Aier Ophthalmology has continuously increased investment, vigorously supported the development of cutting-edge and original academic research in ophthalmology, and built an integrated innovation platform system of medical education and research of "multiple hospitals, multiple institutes, five stations, four centers, four bases, one platform, and one room". It has not only opened up a full-system talent training system from junior college, undergraduate, master's, doctoral to postdoctoral students, but also established an international clinical diagnosis and treatment, clinical training center and scientific research institutions, and made every effort to promote the strategy of eye health ecosystem on a global platform.
In order to popularize the high-level services of artificial intelligence into the whole life cycle of eye health medical services, so as to benefit more grassroots patients, Aier Ophthalmology actively promotes the new development model of "digital ophthalmology", relying on massive ophthalmology clinical data and case resources covering different races, genders, age groups and regions, and has established an eye health big data center covering medical treatment, health education, scientific research, management and services, releasing the "computing power" of digital ophthalmology.
Allowing people to enjoy high-quality and accessible ophthalmic medical services at their doorstep has always been the original intention of Aier Ophthalmology. Aier Ophthalmology hopes that by fully promoting the "1+8+N" strategy and practicing the mission of "enabling all people, regardless of poverty or wealth, to enjoy the right to eye health", the development achievements in the field of ophthalmology will truly benefit every patient, and all mankind will "share the wisdom of global ophthalmology".